| Current State and Future Perspectives on Gastroretentive Drug Delivery Systems J Tripathi, P Thapa, R Maharjan, S Jeong Pharmaceutics 11 (4), 193, 2019 | 174 | 2019 |
| Recent trends and future perspective of pharmaceutical wet granulation for better process understanding and product development P Thapa, J Tripathi, SH Jeong Powder Technology 344, 864-882, 2019 | 85 | 2019 |
| Effects of moisture content and compression pressure of various deforming granules on the physical properties of tablets P Thapa, AR Lee, DH Choi, SH Jeong Powder technology 310, 92-102, 2017 | 62 | 2017 |
| Effects of formulation and process variables on gastroretentive floating tablets with a high-dose soluble drug and experimental design approach P Thapa, S Jeong Pharmaceutics 10 (3), 161, 2018 | 58 | 2018 |
| Development of sorafenib loaded nanoparticles to improve oral bioavailability using a quality by design approach SY Park, Z Kang, P Thapa, YS Jin, JW Park, HJ Lim, JY Lee, SW Lee, ... International journal of pharmaceutics 566, 229-238, 2019 | 53 | 2019 |
| Effects of granulation process variables on the physical properties of dosage forms by combination of experimental design and principal component analysis P Thapa, DH Choi, MS Kim, SH Jeong Asian Journal of Pharmaceutical Sciences 14 (3), 287-304, 2019 | 50 | 2019 |
| Effects of pharmaceutical processes on the quality of ethylcellulose coated pellets: Quality by design approach P Thapa, R Thapa, DH Choi, SH Jeong Powder technology 339, 25-38, 2018 | 16 | 2018 |
| Solubility Enhancement of Domperidone Fast Disintegrating Tablet Using Hydroxypropyl-β-Cyclodextrin by Inclusion Complexation Technique P Thapa, R Thapa, U Budhathoki, P Thapa Pharmacology & Pharmacy 2014, 2014 | 10 | 2014 |
| Formulation optimization and in vitro characterization of orally disintegrating films using a factorial design and mathematical modeling for drug release Y Lee, P Thapa, SH Jeong, MH Woo, DH Choi Chemical and Pharmaceutical Bulletin 65 (2), 166-177, 2017 | 8 | 2017 |
| Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation SJ Park, P Thapa, HJ Seo, ES Park, SH Jeong International Journal of Pharmaceutics 549 (1-2), 388-396, 2018 | 4 | 2018 |
Du Hyung ChoiCollege of Pharmacy, Daegu Catholic University在 cu.ac.kr 的电子邮件经过验证
Du Hyung ChoiCollege of Pharmacy, Daegu Catholic University在 cu.ac.kr 的电子邮件经过验证
Min-Soo KimCollege of Pharmacy, Pusan National University, South Korea在 pusan.ac.kr 的电子邮件经过验证
Panna ThapaKathmandu University在 ku.edu.np 的电子邮件经过验证